🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of sitravat...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06-30
Trial ID
NCT05564338
Treatments Being Tested
This is a single-arm, open-label, multi-center clinical study to evaluate t...
Status
Unknown
Location
Nanfang Hospital, Southern Medical University
Start Date
2024-04
Trial ID
NCT06202716
Treatments Being Tested
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
This is a randomized, prospective, multicenter, open-label, Phase III clini...
Status
Active Not Recruiting
Location
Sir Run Run Shao hospital
Start Date
2024-07-29
Trial ID
NCT06507371
This study compares the efficacy of neoadjuvant low-dose radiotherapy plus ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01-20
Trial ID
NCT06804850
Treatments Being Tested
Evaluation of The Efficacy And Safety of Tislelizumab (PD-1) Monoclonal Ant...
Status
Unknown
Location
Multiple Locations
Start Date
2024-05-01
Trial ID
NCT06394791
Treatments Being Tested
Study on the therapeutic effect of different infusion times on tislelizumab...
Status
Recruiting
Location
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine (Qingchun Campus) 3 Qingchun Road East, Shangcheng District, Hangzhou, Zhejiang, China
Start Date
2025-12-01
Trial ID
NCT07243691
Treatments Being Tested
This Phase 3 study was a randomized, double-blind, placebo-controlled, mult...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2019-07-22
Trial ID
NCT04005716
Treatments Being Tested
In this study, the investigators will use Tislelizumab combined with LM-302...
Status
Recruiting
Location
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Start Date
2026-04-21
Trial ID
NCT07569068
Treatments Being Tested
The objective of this study is to assess the overall response rate, evaluat...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-01-09
Trial ID
NCT05661955
Treatments Being Tested